ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2047-9158
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein ; volume:11 ; number:1 ; day:26 ; month:12 ; year:2022 ; pages:1-14 ; date:12.2022
Translational neurodegeneration ; 11, Heft 1 (26.12.2022), 1-14, 12.2022

Creator
Bonvicini, Gillian
Syvänen, Stina
Andersson, Ken G.
Haaparanta-Solin, Merja
López-Picón, Francisco
Sehlin, Dag
Contributor
SpringerLink (Online service)

DOI
10.1186/s40035-022-00324-y
URN
urn:nbn:de:101:1-2023030721012936013096
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Bonvicini, Gillian
  • Syvänen, Stina
  • Andersson, Ken G.
  • Haaparanta-Solin, Merja
  • López-Picón, Francisco
  • Sehlin, Dag
  • SpringerLink (Online service)

Other Objects (12)

A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice

A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice

Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease

Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer’s disease

SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer’s disease

Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease

Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease

Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease

Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease

Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice

Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice

Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease

Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

Related objects